Cancer markers may be present early during human development Researchers have uncovered a link between the genomes of cells originating in the neural crest and development of tumors -- a discovery that could lead to new ways to diagnose and treat cancer
Oral contraceptives have prevented about 200,000 cases of endometrial cancer in the last decade Use of oral contraceptives (usually referred to as "the pill"), even for just a few years, gives substantial long-term protection against endometrial (womb) cancer, and the longer the pill is used the greater the reduction in risk, according to a detailed re-analysis of all the available evidence.
England still struggling to close the gap in cancer survival Cancer survival in England remains lower than countries with similar healthcare systems, according to a new study. The research compared survival for colon, breast, lung, ovarian, rectal and stomach cancers in England, Australia, Canada, Denmark, Norway and Sweden between 1995 and 2009, and survival trends in England up to 2012.
Topical gel proves safe, effective treatment for patients with skin t cell lymphoma Results of a phase one trial show that an investigational topical drug, resiquimod gel, causes regression of both treated and untreated tumor lesions and may completely remove cancerous cells from both sites in patients with early stage cutaneous T cell lymphoma (CTCL) – a rare type of non-Hodgkin lymphoma that affects the skin. Currently, there is no cure for CTCL aside from a bone marrow transplant. However, the new study shows that the topical gel can eliminate malignant T cells, leading to diminished lesions.
Neutrophil and cancer cell 'crosstalk' underlies oral cancer metastasis An abnormal immune response or 'feedback loop' could very well be the underlying cause of metastases in oral cancers, according to research that has unearthed a significant connection between the inflammatory response of a very specific form of immune cells, neutrophils, and the spread of this deadly disease.